SCHEMBL731058

SCHEMBL731058

[c]1cc(-c2ccccc2)cc(N2CCCC2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.45
▸ HTR7 P34969 1/20 0.45
▸ CHKA P35790 2/20 0.42
▸ ALDH1A1 P00352 6/20 0.39
▸ HSD17B10 Q99714 5/20 0.39
▸ TP53 P04637 3/20 0.39
▸ TSHR P16473 3/20 0.39
▸ USP2 O75604 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HPGD P15428 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ALOX15 P16050 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060017 0.78 ALDH1A1 (0.40) ALDH1A1MAPK1HPGDNPC1RAB9A
SCHEMBL27497441 0.77 HTR1A (0.70) HTR1AHTR7ALDH1A1HSD17B10TP53
SCHEMBL6561470 0.74 CHKA (0.59) CHKAALDH1A1HSD17B10TP53TSHR
SCHEMBL619546 0.73 ALDH1A1 (0.53) ALDH1A1HSD17B10CYP1A2CYP3A4MAPK1
SCHEMBL4027686 0.72 CHKA (0.57) CHKAALDH1A1HSD17B10TP53TSHR
SCHEMBL17857889 0.72 HTR1A (0.53) HTR1AHTR7CHKAALDH1A1HSD17B10
SCHEMBL28980880 0.71 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP1A2CYP3A4MAPK1
Water SCHEMBL3988826 0.71 L3MBTL1 (0.59) CHKAALDH1A1HSD17B10TP53TSHR
SCHEMBL21382696 0.71 ALDH1A1 (0.50) ALDH1A1HSD17B10USP2CYP1A2CYP3A4
SCHEMBL2450702 0.71 ALDH1A1 (0.50) ALDH1A1HSD17B10USP2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 — — EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 — — US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 — — EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 — — US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 HTR1A 1961/4885HTR7 1777/4885CHKA 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback